Publicaciones en las que colabora con Cristóbal Belda Iniesta (32)

2012

  1. Expression profile as predictor of relapse after adjuvant treatment in gastric cancer

    Journal of Gastrointestinal Cancer, Vol. 43, Núm. 2, pp. 181-189

  2. Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target

    International Journal of Radiation Oncology Biology Physics, Vol. 84, Núm. 5, pp. 1151-1158

2011

  1. A combined strategy of SAGE and quantitative PCR provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer

    Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4145-4154

  2. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy

    Colorectal Disease, Vol. 13, Núm. 9, pp. 989-998

2009

  1. Chemotherapy for colorectal cancer in the elderly: Whom to treat and what to use

    Cancer Treatment Reviews, Vol. 35, Núm. 3, pp. 246-254

  2. Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: Multicenter phase II study

    Cancer Chemotherapy and Pharmacology, Vol. 63, Núm. 3, pp. 403-409

  3. EPO-R expression patterns in resected gastric adenocarcinoma followed by adjuvant chemoradiation treatment

    Pathology and Oncology Research, Vol. 15, Núm. 1, pp. 1-10

  4. KRAS mutations in primary colorectal cancer tumors and related metastases: A potential role in prediction of lung metastasis

    PLoS ONE, Vol. 4, Núm. 12

  5. Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy

    International Journal of Colorectal Disease, Vol. 24, Núm. 7, pp. 741-748

  6. The combination of FOLFOX4 and bevacizumab may enable salvage surgery of unresectable liver metastases in colon cancer

    Anti-Cancer Drugs, Vol. 20, Núm. SPEC. ISS. 1

2008

  1. Cardiac toxicity: Old and new issues in anti-cancer drugs

    Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 35-46

  2. EGFR and colon cancer: A clinical view

    Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 6-13

  3. Retroperitoneal Castleman's disease with colon cancer. A rare association

    Clinical and Translational Oncology, Vol. 10, Núm. 4, pp. 238-240

2007

  1. Carcinoma de pulmón

    Tratado de medicina paliativa y tratamiento de soporte del paciente con cáncer (Editorial Médica Panamericana), pp. 111-128

  2. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study

    Lancet Oncology, Vol. 8, Núm. 10, pp. 889-897

  3. Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells

    Cancer Biology and Therapy, Vol. 6, Núm. 10, pp. 1600-1605

  4. Molecular markers in colorectal cancer: Genetic bases for a customised treatment

    Clinical and Translational Oncology, Vol. 9, Núm. 9, pp. 549-554

  5. New screening method for lung cancer by detecting volatile organic compounds in breath

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 364-368

  6. Phospholipid Hydroperoxide Glutathione Peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma

    Free Radical Research, Vol. 41, Núm. 6, pp. 681-687

  7. Síndrome de anorexia-caquexia: aspectos generales y fisiopatología

    Tratado de medicina paliativa y tratamiento de soporte del paciente con cáncer (Editorial Médica Panamericana), pp. 405-409